Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.

Li J, Zhou JY, Yu Y, Chen XM, Luo WL, Lakang Y, Zuo JX, Yang ZS, Xu HB, Liang YB, Wang QB, Li YK, Shang LM, Ke Y.

Open source

DOI
10.2147/jhc.s622555
Published
2026-10-25
Container
J Hepatocell Carcinoma
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jhc.s622555,
  title = {Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.},
  author = {Li J and  Zhou JY and  Yu Y and  Chen XM and  Luo WL and  Lakang Y and  Zuo JX and  Yang ZS and  Xu HB and  Liang YB and  Wang QB and  Li YK and  Shang LM and  Ke Y.},
  year = {2026},
  journal = {J Hepatocell Carcinoma},
  doi = {10.2147/jhc.s622555},
  url = {https://doi.org/10.2147/jhc.s622555}
}

RIS

TY  - JOUR
TI  - Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.
AU  - Li J
AU  -  Zhou JY
AU  -  Yu Y
AU  -  Chen XM
AU  -  Luo WL
AU  -  Lakang Y
AU  -  Zuo JX
AU  -  Yang ZS
AU  -  Xu HB
AU  -  Liang YB
AU  -  Wang QB
AU  -  Li YK
AU  -  Shang LM
AU  -  Ke Y.
PY  - 2026
JO  - J Hepatocell Carcinoma
DO  - 10.2147/jhc.s622555
UR  - https://doi.org/10.2147/jhc.s622555
ER  - 

APA

J, L., JY, Z., Y, Y., XM, C., WL, L., Y, L., JX, Z., ZS, Y., HB, X., YB, L., QB, W., YK, L., LM, S., & Y., K. (2026). Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.. J Hepatocell Carcinoma. https://doi.org/10.2147/jhc.s622555

Source records